|
Novel Strategies for Precision T-cell Therapies
|
5R01CA198095-03
|
$520,564
|
|
ALMO, STEVEN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
MOTILITY AND INVASION
|
5P01CA100324-16
|
$2,028,990
|
|
CONDEELIS, JOHN
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Dissecting Skp2 functions in pRb and p53 doubly deficient tumorigenesis
|
5R01CA201458-03
|
$382,013
|
|
ZHU, LIANG
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Molecular Biology in Clinical Oncology Workshop
|
5R25CA057732-26
|
$249,978
|
|
SAWYERS, CHARLES
|
AMERICAN ASSOCIATION FOR CANCER RESEARCH
|
|
Enhanced Training and Mentorship of Hematologic Oncologists
|
2R25CA168526-06
|
$306,150
|
|
SUNG, LILLIAN
|
AMERICAN SOCIETY OF HEMATOLOGY
|
|
(PQ3) Identifying Novel Pharmacologic Risk factors for Common Non-AIDS Defining Cancers in Individuals with Well-controlled HIV Infection
|
5R01CA206476-03
|
$706,386
|
|
CHIAO, ELIZABETH
|
BAYLOR COLLEGE OF MEDICINE
|
|
THE INITIATION AND REGULATION OF INFLAMMATION IN NEUROBLASTOMA
|
5R01CA116548-13
|
$249,638
|
|
METELITSA, LEONID
|
BAYLOR COLLEGE OF MEDICINE
|
|
CD25-mediated feedback control of BCR-signaling and its oncogenic mimics
|
5R01CA213138-02
|
$395,738
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Metabolic basis of B cell lineage leukemia relapse
|
5R35CA197628-03
|
$1,035,561
|
|
MUSCHEN, MARKUS
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
Cancer Center Support Grant
|
2P30CA033572-35
|
$2,543,187
|
|
ROSEN, STEVEN
|
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE
|
|
BRAFV600E and VEGFR2 synergize to trigger papillary thyroid cancer progression
|
5R01CA181183-05
|
$361,050
|
|
NUCERA, CARMELO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Randomized Trial of a Mammography Decision Aid for Women Aged 75 and Older
|
5R01CA181357-05
|
$414,552
|
|
SCHONBERG, MARA
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Characterizing the signaling pathways that regulate Skp2 oncogenic function
|
5R01CA200573-03
|
$395,738
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Targeting the APC/Cdc20 E3 ubiquitin ligase for chemoradiation sensitization
|
5R01CA200651-03
|
$383,385
|
|
WEI, WENYI
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Role of Insulin Receptor Substrates in Kras-driven lung cancer
|
5R01CA211944-02
|
$404,888
|
|
KALAANY, NADA
|
BOSTON CHILDREN'S HOSPITAL
|
|
Improving Accuracy and Reliability in Cancer Screening Tests
|
1R01CA226805-01
|
$313,533
|
|
NELSON, KERRIE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
The Effects of Vitamin D on Mammographic Density and Breast Tissue
|
5R01CA178263-05
|
$512,511
|
|
REXRODE, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Redefining Normal: personalized CA125 cutpoints for ovarian cancer screening
|
5R01CA193965-03
|
$371,704
|
|
TERRY, KATHRYN
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Targeting Brain Tumor Stem Cells In The Hypoxic Microenvironment
|
5R01CA187780-04
|
$362,569
|
|
BAR, ELI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Oncology Nurse IMPACT:Improving Communication with Patients about Clinical Trial
|
5R25CA177574-05
|
$130,966
|
|
DALY, BARBARA
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
2P30CA043703-28
|
$5,637,954
|
$56,380
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Case Comprehensive Cancer Center Support Grant
|
3P30CA043703-28S1
|
$249,965
|
$2,500
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Contribution of Gynecologic and Breast Cancer Biospecimens from African American women to HCMI
|
3P30CA043703-28S2
|
$48,000
|
$480
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Cancer-focused Summer Undergraduate Research (CanSUR) Program
|
1R25CA225461-01
|
$323,501
|
|
JACKSON, MARK
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Glial tumor image-guided surgery and treatment
|
5R01CA209921-03
|
$519,467
|
|
HOLLER, EGGEHARD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Identification of microbial biomarkers for hepatocellular carcinoma in a multi-ethnic population of patients with nonalcoholic fatty liver disease
|
1R21CA225623-01
|
$176,514
|
|
HUSSAIN, SHEHNAZ
|
CEDARS-SINAI MEDICAL CENTER
|
|
Connecting Genomic Alterations in Liposarcomas with Drug Responses and Identification of New Therapeutic Approaches
|
5R01CA200992-03
|
$363,125
|
|
KOEFFLER, HAROLD
|
CEDARS-SINAI MEDICAL CENTER
|
|
Targeting Oncogenic ALK Signaling in Neuroblastoma
|
5R01CA140198-10
|
$374,304
|
|
MOSSE, YAEL
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
Towards selective androgen deprivation by targeting androgen activation of SRF
|
5R01CA166440-05
|
$338,994
|
|
HEEMERS, HANNELORE
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Tissue Specific Regulation of Diabetes-Associated Cancer Growth
|
5R01CA177771-05
|
$328,888
|
|
STENINA, OLGA
|
CLEVELAND CLINIC LERNER COM-CWRU
|
|
Molecular Sequelae of Myeloma-Bone Marrow Interactions: Therapeutic Applications
|
5R01CA050947-26
|
$301,545
|
|
ANDERSON, KENNETH
|
DANA-FARBER CANCER INST
|
|
Stroma-mediated clonal evolution in Multiple Myeloma
|
5R01CA181683-05
|
$353,770
|
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
|
5R01CA205954-03
|
$703,249
|
|
GHOBRIAL, IRENE
|
DANA-FARBER CANCER INST
|
|
Humanized bone marrow-like model to study patient-derived myeloma xenografts
|
5R01CA196664-03
|
$537,912
|
|
MITSIADES, CONSTANTINE
|
DANA-FARBER CANCER INST
|
|
Intratumor heterogeneity underlying treatment resistance in HER2+ breast tumors
|
5U01CA195469-04
|
$671,607
|
|
POLYAK, KORNELIA
|
DANA-FARBER CANCER INST
|
|
Functional analysis of the Tip60 complex
|
5R01CA093602-14
|
$311,400
|
|
PRICE, BRENDAN
|
DANA-FARBER CANCER INST
|
|
The function of cyclin C in tumorigenesis
|
5R01CA190509-04
|
$453,569
|
|
SICINSKI, PETER
|
DANA-FARBER CANCER INST
|
|
Smartphone Enabled Point-of-Care Detection of Serum Markers of Liver Cancer
|
5UG3CA211232-02
|
$385,158
|
|
CHILKOTI, ASHUTOSH
|
DUKE UNIVERSITY
|
|
To enhance breast cancer survivorship of Asian Americans
|
5R01CA203719-03
|
$576,193
|
|
IM, EUN-OK
|
DUKE UNIVERSITY
|
|
Experimental Therapy for Brain Tumors
|
1P01CA225622-01
|
$2,170,371
|
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
|
Developing knowledge models to enable rapid learning in radiation therapy
|
5R01CA201212-03
|
$441,708
|
|
WU, QINGRONG
|
DUKE UNIVERSITY
|
|
The PDX Integrator- Re-purposing KOMP2 informatics to widely disseminate data from Patient Derived Xenografts
|
5U24CA204781-03
|
$413,604
|
|
PARKINSON, HELEN
|
EUROPEAN MOLECULAR BIOLOGY LABORATORY
|
|
Training Program in Research Ethics in the Americas
|
5R25TW001605-19
|
$45,706
|
|
LUNA, FLORENCIA
|
FACULTAD LATINOAMERICANA DE CIENCIAS SOCIALES
|
|
Adult Leukemia Research Center
|
2P01CA018029-42A1
|
$3,990,001
|
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Serrated Colorectal Cancer: An Emerging Disease Subtype
|
5R01CA196337-04
|
$885,578
|
|
NEWCOMB, POLLY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Validation of a disposable biospecimen collection system with integral refrigeration for preserving the phosphoproteome
|
1R21CA225507-01
|
$280,976
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Proteogenomic studies aimed at understanding ovarian tumor responses to agents targeting the DNA damage response and translating this knowledge into clinical benefit
|
5U01CA214114-02
|
$1,441,604
|
|
PAULOVICH, AMANDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alpha-Catenin in Regulation of Tissue Homeostasis and Cancer
|
5R01CA179914-05
|
$436,778
|
|
VASIOUKHIN, VALERI
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
PALS: Prostate Cancer Active Lifestyle Study
|
5R01CA184075-04
|
$1
|
|
WRIGHT, JONATHAN
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
Total relevant funding to Agent Orange/Dioxin Related for this search: $802,526
|